Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2020 |
Income Tax Disclosure [Abstract] |
|
Schedule of Components of Income Tax Benefit |
The components of the income tax expense (benefit) for continuing operations are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2020 |
|
2019 |
|
2018 |
Current expense (benefit): |
|
|
|
|
|
Federal |
$ |
10,889 |
|
|
$ |
89,471 |
|
|
$ |
— |
|
State |
589 |
|
|
3,103 |
|
|
424 |
|
Foreign |
23 |
|
|
(66) |
|
|
(158) |
|
|
11,501 |
|
|
92,508 |
|
|
266 |
|
Deferred expense (benefit): |
|
|
|
|
|
Federal |
(15,672) |
|
|
74,627 |
|
|
29,928 |
|
State |
(3,382) |
|
|
202 |
|
|
(185) |
|
|
$ |
(7,553) |
|
|
$ |
167,337 |
|
|
$ |
30,009 |
|
|
Schedule of Effective Income Tax Rate Reconciliation |
A reconciliation of income tax expense (benefit) from continuing operations to the amount computed by applying the statutory federal income tax rate to the net income (loss) from continuing operations is summarized as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2020 |
|
2019 |
|
2018 |
Tax at federal statutory rate |
$ |
(2,213) |
|
|
$ |
167,294 |
|
|
$ |
36,400 |
|
State, net of federal benefit |
(1,456) |
|
|
2,466 |
|
|
1,635 |
|
Contingent liabilities |
(278) |
|
|
18 |
|
|
948 |
|
Share-based compensation |
(362) |
|
|
(819) |
|
|
(8,131) |
|
FDII |
(1,652) |
|
|
(402) |
|
|
— |
|
Research and development credits |
(699) |
|
|
(879) |
|
|
(2,758) |
|
Change in uncertain tax positions |
(650) |
|
|
441 |
|
|
858 |
|
Rate change for changes in federal or state law |
(173) |
|
|
(210) |
|
|
178 |
|
Provision to return adjustments |
(4,803) |
|
|
(184) |
|
|
(150) |
|
Foreign tax differential on income/loss of foreign subsidiaries |
(3,839) |
|
|
57 |
|
|
(14) |
|
Change in valuation allowance |
(121,876) |
|
|
(1,193) |
|
|
(4,225) |
|
Sale of Vernalis R&D |
127,372 |
|
|
— |
|
|
— |
|
Expired NOLs and credits |
— |
|
|
— |
|
|
3,054 |
|
Change in derivatives |
— |
|
|
— |
|
|
615 |
|
Other |
3,076 |
|
|
748 |
|
|
1,599 |
|
|
$ |
(7,553) |
|
|
$ |
167,337 |
|
|
$ |
30,009 |
|
|
Schedule of Deferred Tax Assets and Liabilities |
Deferred tax assets (liabilities) are comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2020 |
|
2019 |
|
(in thousands) |
Deferred tax assets: |
|
|
|
Net operating loss carryforwards |
$ |
64,147 |
|
|
$ |
150,727 |
|
Research credit carryforwards |
19,623 |
|
|
14,843 |
|
Stock Compensation |
11,994 |
|
|
9,544 |
|
Other |
13,120 |
|
|
10,602 |
|
|
108,884 |
|
|
185,716 |
|
Valuation allowance for deferred tax assets |
(24,858) |
|
|
(141,338) |
|
Net deferred tax assets |
$ |
84,026 |
|
|
$ |
44,378 |
|
|
|
|
|
Deferred tax liabilities: |
|
|
|
Identified intangibles |
(119,381) |
|
|
(40,768) |
|
Other |
(4,923) |
|
|
(10,939) |
|
Net deferred tax liabilities |
$ |
(124,304) |
|
|
$ |
(51,707) |
|
|
|
|
|
Deferred income taxes, net |
$ |
(40,278) |
|
|
$ |
(7,329) |
|
|
Schedule of Unrecognized Tax Benefits |
A reconciliation of the amount of unrecognized tax benefits at December 31, 2020, 2019 and 2018 is as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
2020 |
|
2019 |
|
2018 |
Balance at beginning of year |
$ |
28,736 |
|
|
$ |
30,289 |
|
|
$ |
29,363 |
|
Additions based on tax positions related to the current year |
3,911 |
|
|
543 |
|
|
1,247 |
|
Additions for tax positions of prior years |
179 |
|
|
— |
|
|
336 |
|
Reductions for tax positions of prior years |
(955) |
|
|
(2,096) |
|
|
(657) |
|
Balance at end of year |
$ |
31,871 |
|
|
$ |
28,736 |
|
|
$ |
30,289 |
|
|